Published Studies Related to Lisinopril and Hydrochlorothiazide (Lisinopril / Hydrochlorothiazide)
Well-designed clinical trials related to Lisinopril and Hydrochlorothiazide (Lisinopril / Hydrochlorothiazide)
Aggressive antihypertensive strategies based on hydrochlorothiazide, candesartan or lisinopril decrease left ventricular mass and improve arterial compliance in patients with type II diabetes mellitus and hypertension. [2006.08]
Effect of telmisartan/hydrochlorothiazide vs lisinopril/hydrochlorothiazide combination on ambulatory blood pressure and cognitive function in elderly hypertensive patients. [2006.03]
Aggressive antihypertensive therapy based on hydrochlorothiazide, candesartan or lisinopril as initial choice in hypertensive type II diabetic individuals: effects on albumin excretion, endothelial function and inflammation in a double-blind, randomized clinical trial. [2005.06]
Clarithromycin suspension: bioequivalence studies on two different strengths. [2004.09]
Comparison of valsartan 160 mg with lisinopril 20 mg, given as monotherapy or in combination with a diuretic, for the treatment of hypertension: the Blood Pressure Reduction and Tolerability of Valsartan in Comparison with Lisinopril (PREVAIL) study. [2004.06]
Comparative bioavailability of two immediate-release tablets of lisinopril/hydrochlorothiazide in healthy volunteers. [2003.07]
Lisinopril-mediated regression of myocardial fibrosis in patients with hypertensive heart disease. [2000.09.19]
Comparison of the AT1-receptor blocker, candesartan cilexetil, and the ACE inhibitor, lisinopril, in fixed combination with low dose hydrochlorothiazide in hypertensive patients. [2000.04]
Lisinopril versus enalapril: evaluation of trough:peak ratio by ambulatory blood pressure monitoring. [1999.06]
Comparison of telmisartan with lisinopril in patients with mild-to-moderate hypertension. [1999.05]
Lisinopril versus hydrochlorothiazide in obese hypertensive patients: a multicenter placebo-controlled trial. Treatment in Obese Patients With Hypertension (TROPHY) Study Group. [1997.07]
[Comparison of antihypertensive and metabolic effects of lisinopril 20 mg/hydrochlorothiazide 12.5 mg fixed combination and captopril 50 mg/hydrochlorothiazide 25 mg fixed combination] [1997.05]
Effects of lisinopril or lisinopril/hydrochlorothiazide compared with adjusting of previous medication and intensifying non-pharmacological treatment in patients with mild to moderate hypertension. [1997.02]
Valsartan, a new angiotensin II receptor antagonist: a double-blind study comparing the incidence of cough with lisinopril and hydrochlorothiazide. [1997.02]
[Comparison of metabolic and hemodynamic effects of hydrochlorothiazide in monotherapy and in association with lisinopril. An Italian multicenter study] [1995.09]
Comparison of the hemodynamic and metabolic effects of low-dose hydrochlorothiazide and lisinopril treatment in obese patients with high blood pressure. [1995.05]
Comparison of the efficacy and tolerability of an angiotensin converting enzyme inhibitor (lisinopril) versus a calcium channel antagonist (diltiazem SR) in the treatment of moderate to severe hypertension. [1994.07]
Antihypertensive effectiveness of low-dose lisinopril-hydrochlorothiazide combination. A large multicenter study. Lisinopril-Hydrochlorothiazide Group. [1994.04.11]
[Evaluation of lisinopril and lisinopril-hydrochlorothiazide combination in mild to moderate arterial hypertension] [1994.01]
A comparison of lisinopril and nifedipine in the treatment of mild to moderate hypertension. A multicentre study. [1994]
[Evaluation of the antihypertensive efficacy of lisinopril and captopril associated with hydrochlorothiazide by ambulatory measurement of arterial pressure] [1993.12]
Effects of lisinopril and hydrochlorothiazide on platelet function and blood rheology in essential hypertension: a randomly allocated double-blind study. [1993.05]
Effects of hydrochlorothiazide, amiloride, and lisinopril on the metabolic response to adrenaline infusions in normal subjects. [1992.06]
Effects of lisinopril and low-dose trichlormethiazide on lipoprotein metabolism in patients with mild to moderate hypertension. [1992.06]
Comparison of the effects of isradipine and lisinopril on left ventricular structure and function in essential hypertension. [1992.05.01]
[Evaluation of the safety and efficacy of the lisinopril + hydrochlorothiazide and captopril + hydrochlorothiazide combinations in the treatment of essential arterial hypertension] [1992.01]
A comparison of the effect of lisinopril and hydrochlorothiazide on electrolyte balance in essential hypertension. [1992]
Lisinopril-hydrochlorothiazide combination compared with the monocomponents in elderly hypertensive patients. [1991.12]
The pharmacokinetics of co-administered lisinopril and hydrochlorothiazide. [1991.12]
Controlling hypertension: lisinopril-hydrochlorothiazide vs captopril-hydrochlorothiazide. An Italian multicentre study. [1991.12]
Lisinopril-hydrochlorothiazide combination vs lisinopril for the treatment of hypertension. [1991.12]
Introduction to lisinopril-hydrochlorothiazide combination. [1991.12]
Comparison of long-term hemodynamic effects at rest and during exercise of lisinopril plus sodium restriction versus hydrochlorothiazide in essential hypertension. [1990.02.01]
ACE inhibitors in mild to moderate hypertension: comparison of lisinopril and captopril administered once daily. French Cooperative Study Group. [1989.06]
Lisinopril in essential hypertension: a six month comparative study with nifedipine. [1987.12]
Well-designed clinical trials possibly related to Lisinopril and Hydrochlorothiazide (Lisinopril / Hydrochlorothiazide)
Effects of sodium restriction and hydrochlorothiazide on RAAS blockade efficacy
in diabetic nephropathy: a randomised clinical trial. [2014]
Antihypertensive therapy and cerebral hemodynamics in executive mild cognitive
impairment: results of a pilot randomized clinical trial. [2013]
Pharmacotherapy review of chronic pediatric hypertension. [2011.10]
[Merits of paracetamol in osteoarthritic hypertensive patients]. [2011.03]
A Polypill for primary prevention of cardiovascular disease: a feasibility study of the World Health Organization. [2011.01.05]
Effect of self-measurement of blood pressure on adherence to treatment in patients with mild-to-moderate hypertension. [2010.03]
Assessing medication adherence simultaneously by electronic monitoring and pill count in patients with mild-to-moderate hypertension. [2010.02]
Effect of self-measurement of blood pressure on adherence to treatment in
patients with mild-to-moderate hypertension. [2010]
Assessing medication adherence simultaneously by electronic monitoring and pill
count in patients with mild-to-moderate hypertension. [2010]
The rationale and design of the antihypertensives and vascular, endothelial, and cognitive function (AVEC) trial in elderly hypertensives with early cognitive impairment: role of the renin angiotensin system inhibition. [2009.11.18]
Selective cyclooxygenase-2 (COX-2) inhibition reduces proteinuria in renal patients. [2009.04]
Gender difference in the response to an angiotensin-converting enzyme inhibitor and a diuretic in hypertensive patients of African descent. [2004.06]
Cardiovascular events in elderly patients with isolated systolic hypertension. A subgroup analysis of treatment strategies in STOP-Hypertension-2. [2004]
Effects of non-steroidal anti-inflammatory drugs on hypertension control using angiotensin converting enzyme inhibitors and thiazide diuretics. [2001.10]
[Calcium antagonists in cardiovascular disease. Clinical evidence from morbidity and mortality trials] [2000]
Randomised trial of old and new antihypertensive drugs in elderly patients: cardiovascular mortality and morbidity the Swedish Trial in Old Patients with Hypertension-2 study. [1999.11.20]
Nocturnal reduction of blood pressure and the antihypertensive response to a diuretic or angiotensin converting enzyme inhibitor in obese hypertensive patients. TROPHY Study Group. [1998.08]
Comparison of different fixed antihypertensive combination drugs: a double-blind, placebo-controlled parallel group study. [1997.01]
ACE inhibitors, angiotensin II antagonists and cough. The Losartan Cough Study Group. [1995.11]
Modulation of the renin-angiotensin-aldosterone system and cough. [1995.08]
Effects of different antihypertensive drugs on plasma fibrinogen in hypertensive patients. [1995.05]
Effects of modulators of the renin-angiotensin-aldosterone system on cough. Losartan Cough Study Group. [1994.12]
Association between cough and angiotensin converting enzyme inhibitors versus angiotensin II antagonists: the design of a prospective, controlled study. [1994.07]
Response of ambulatory blood pressure to antihypertensive therapy guided by clinic pressure. [1993.08]
APTH--a trial on ambulatory blood pressure monitoring and treatment of hypertension: objectives and protocol. [1993]
Glucose and lipid metabolism in essential hypertension: effects of diuretics and ACE-inhibitors. [1993]
Which anti-hypertensive to add to a beta-blocker: ACE inhibitor or diuretic? [1992.04]
Treatment of arterial hypertension in diabetic humans: importance of therapeutic selection. [1992.04]
Diltiazem: its place in the antihypertensive armamentarium. [1991]
ACE inhibition and pressor responsiveness to norepinephrine in hypertensive patients. [1990.05]
Other research related to Lisinopril and Hydrochlorothiazide (Lisinopril / Hydrochlorothiazide)
Comparison of some physical parameters of whole and scored lisinopril and lisinopril/hydrochlorthiazide tablets. [2008.11]
Effects of fixed combination of lisinopril plus hydrochlorothiazide on regression of left ventricular hypertrophy in patients with essential hypertension: an opened, multi-centre, prospective clinical trial. [2008.08]
Fixed combination lisinopril plus hydro-chlorothiazide in the treatment of essential arterial hypertension: an opened, multi-centre, prospective clinical trial. [2007.11]
Influence of tablet splitting on content uniformity of lisinopril/hydrochlorthiazide tablets. [2007.11]
A comparison of the tolerability of the direct renin inhibitor aliskiren and lisinopril in patients with severe hypertension. [2007.10]
A comparison of the tolerability of the direct renin inhibitor aliskiren and lisinopril in patients with severe hypertension. [2007.05.31]
A case of fatal necrotizing pancreatitis: complication of hydrochlorothiazide and lisinopril therapy. [2007.02]
Tolerability and blood pressure-lowering efficacy of the combination of amlodipine plus valsartan compared with lisinopril plus hydrochlorothiazide in adult patients with stage 2 hypertension. [2007.02]
Hydrochlorothiazide increases plasma or tissue angiotensin-converting enzyme-inhibitor drug levels in rats with myocardial infarction: differential effects on lisinopril and zofenopril. [2005.12.19]
Reproducibility and clinical value of nocturnal hypotension: prospective evidence from the SAMPLE study. Study on Ambulatory Monitoring of Pressure and Lisinopril Evaluation. [1998.06]
Long-term evaluation of combined antihypertensive therapy with lisinopril and a thiazide diuretic in patients with essential hypertension. [1997.11]
Antihypertensive effects of combined lisinopril and hydrochlorothiazide in elderly patients with systodiastolic or systolic hypertension: results of a multicenter trial. [1997.11]
Ambulatory blood pressure is superior to clinic blood pressure in predicting treatment-induced regression of left ventricular hypertrophy. SAMPLE Study Group. Study on Ambulatory Monitoring of Blood Pressure and Lisinopril Evaluation. [1997.03.18]
[A multicenter study of lisinopril in the treatment of mild to moderate hypertension] [1995.07]
[The antihypertensive effects of the lisinopril-hydrochlorothiazide combination (Zestoretic) in elderly hypertensive patients. The results of a multicenter study. The Italian Zestoretic Study Group] [1994.10]
The effects of age and renal impairment on the pharmacokinetics of co-administered lisinopril and hydrochlorothiazide. [1991.12]
Review of international safety data for lisinopril-hydrochlorothiazide combination treatment. [1991.12]
Lisinopril versus slow-release nifedipine in the treatment of mild to moderate hypertension: a multicentre study. The Cooperative Study Group. [1989.06]
Clinical experience with lisinopril. Observations on safety and tolerability. [1989.06]
Lisinopril in the treatment of hypertension. [1989.06]
The antihypertensive response to lisinopril: the effect of age in a predominantly black population. [1989.01]
Safety and tolerability of lisinopril in older hypertensive patients. [1988.09.23]
Clinical experience and rationale for angiotensin-converting enzyme inhibition with lisinopril as the initial treatment for hypertension in older patients. [1988.09.23]
Plasma lipid profiles and antihypertensive agents: effects of lisinopril, enalapril, nitrendipine, hydralazine, and hydrochlorothiazide. [1988.07]
Lisinopril. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension and congestive heart failure. [1988.06]
Lisinopril versus lisinopril plus hydrochlorothiazide in essential hypertension. [1988.04.01]
A 52-week comparison of lisinopril, hydrochlorothiazide, and their combination in hypertension. [1987.05]
Other possibly related research studies
Persistence, adherence, and risk of discontinuation associated with commonly prescribed antihypertensive drug monotherapies. [2007.01]
Difficulty in the diagnosis of Cushing disease. [2006.01]
Nebivolol: new therapy update. [2006.09]
Warfarin and royal jelly interaction. [2006.04]
Hypertension in the oncology setting. [2005.12]
Medication adherence before an increase in antihypertensive therapy: a cohort study using pharmacy claims data. [2005.06]
Posting guidelines: a practical and effective way to promote appropriate hypertension treatment. [2005.04]
High prevalence of orthostatic hypotension and its correlation with potentially causative medications among elderly veterans. [2005.04]
The effect of combination therapy on regression of left ventricular hypertrophy in cases with hypertension. [2004.12]
|